Study tests two drug combos to boost success of Life-Saving transplants
NCT ID NCT04994808
Summary
This study aims to find out which of two chemotherapy combinations works better to prepare patients for a donor stem cell transplant. The transplant is a treatment for certain aggressive blood cancers. Researchers are comparing the drugs treosulfan and clofarabine to see which one helps patients live longer without their cancer returning after the transplant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, 98109, United States
Conditions
Explore the condition pages connected to this study.